<p>India is likely to see a rise in Covid-19 infections, <a href="https://www.deccanherald.com/national/forecaster-who-predicted-india-s-covid-peak-sees-new-wave-coming-1015371.html" target="_blank">building into a new -- though smaller -- virus wave that may peak in October</a>, according to a mathematical model by researchers who accurately predicted the brutal surge of cases earlier this year.</p>.<p>The country may see worsening of its outbreak as soon as this month, with the next wave peaking in the best-case scenario with less than 100,000 infections a day, or nearly 150,000 in the worst scenario, according to estimates by researchers led by Mathukumalli Vidyasagar and Manindra Agrawal at Indian Institute of Technology in Hyderabad and Kanpur respectively.</p>.<p>States with high Covid rates, such as Kerala and Maharashtra, could “skew the picture,” according to Vidyasagar. </p>.<p>A surge in Covid cases in Kerala, which is now leading the country in the number of daily infections and total cases, <a href="https://www.deccanherald.com/opinion/first-edit/kerala-s-covid-19-surge-a-concern-1014807.html" target="_blank">has already caused concern </a>with a central team visiting the state to assess the situation.</p>.<p>Its neighbouring state, Karnataka, has also been witnessing a <a href="https://www.deccanherald.com/state/covid-19-concern-as-karnataka-districts-along-kerala-border-inch-towards-5-tpr-1014794.html" target="_blank">surge in Covid-19 cases in districts along the Kerala border</a>. As per the state war room report, four districts along the Kerala border have a weekly TPR (average of seven days from July 23 to 29) inching towards 5 per cent: Dakshina Kannada (4.42%), Chikkamagaluru (3.67%), Kodagu (3.44%) and Udupi (3.39%). </p>.<p>On Sunday, for the first time, Dakshina Kannada <a href="https://www.deccanherald.com/state/top-karnataka-stories/dakshina-kannada-overtakes-bengaluru-in-daily-covid-cases-1015323.html" target="_blank">overtook Bengaluru Urban in the number of Covid cases </a>posted on a single day. It recorded 410 new cases, while Bengaluru Urban registered 409 fresh infections. This represents a 75.7 per cent increase in cases in Dakshina Kannada over the past week.</p>.<p>This forced the Karnataka government<a href="https://www.deccanherald.com/state/top-karnataka-stories/vaccinated-travellers-from-kerala-maharashtra-still-need-rt-pcr-test-report-to-enter-karnataka-1014890.html" target="_blank"> to tighten norms for travellers from Kerala and Maharashtra</a>. All those travelling to Karnataka from these two states will now have to produce a RT-PCR negative certificate that is not older than 72 hours, apart from showing a vaccination certificate stating that the person has taken both doses of vaccine.</p>.<p>Similarly, Tamil Nadu, which saw a marginal increase in Covid cases in the past few days, <a href="https://www.deccanherald.com/national/south/rt-pcr-test-mandatory-for-those-entering-tamil-nadu-from-kerala-1015246.html" target="_blank">has made it mandatory to carry RT-PCR test reports</a> from August 5 for those coming from Kerala. The state government has also empowered district collectors <a href="https://www.deccanherald.com/national/south/as-covid-19-cases-rise-marginally-tamil-nadu-goes-for-local-containment-1015278.html" target="_blank">to go in for local containment efforts</a>, including imposing additional restrictions in their area if the need arises.</p>.<p>Conjuring up fears of a third Covid-19 wave, a nationwide survey <a href="https://www.deccanherald.com/national/survey-indicates-travel-plans-by-28-amid-third-covid-wave-fears-1015350.html" target="_blank">has revealed that 28 per cent of the respondents have travel plans in August-September</a>. A substantial 54 per cent of these travellers indicated that they would visit their friends and family, while 26 per cent want to head to holiday destinations, the survey report said.</p>.<p>On the Covid-19 vaccine front, a recent ICMR study said that Bharat Biotech's <a href="https://www.deccanherald.com/national/covaxin-effective-against-delta-plus-variant-icmr-study-1015437.html" target="_blank">Covaxin is effective against the Delta Plus variant</a>.</p>.<p>In another major development, Mumbai-based Glenmark pharmaceuticals has signed a long term strategic partnership with Canadian biotech firm SaNOtize Research & Development Corp. to manufacture, market and distribute its breakthrough <a href="https://www.deccanherald.com/business/business-news/glenmark-pharma-signs-agreement-for-nasal-spray-used-for-covid-19-treatment-1015420.html" target="_blank">Nitric Oxide Nasal Spray (NONS) for Covid-19 treatment</a> in India and other Asian markets. </p>.<p>Meanhwile, the drug regulator said on Monday that Johnson & Johnson <a href="https://www.deccanherald.com/business/jj-withdraws-proposal-for-speedy-covid-19-vaccine-approval-in-india-1015449.html" target="_blank">withdrew its proposal </a>seeking accelerated approval of its Covid-19 vaccine in the country, without giving additional details. The US-based company had said in April it was seeking an approval to conduct a clinical study of its Janssen Covid-19 vaccine candidate in India. Trials in the United States at that time were paused on reports of rare blood clots.</p>
<p>India is likely to see a rise in Covid-19 infections, <a href="https://www.deccanherald.com/national/forecaster-who-predicted-india-s-covid-peak-sees-new-wave-coming-1015371.html" target="_blank">building into a new -- though smaller -- virus wave that may peak in October</a>, according to a mathematical model by researchers who accurately predicted the brutal surge of cases earlier this year.</p>.<p>The country may see worsening of its outbreak as soon as this month, with the next wave peaking in the best-case scenario with less than 100,000 infections a day, or nearly 150,000 in the worst scenario, according to estimates by researchers led by Mathukumalli Vidyasagar and Manindra Agrawal at Indian Institute of Technology in Hyderabad and Kanpur respectively.</p>.<p>States with high Covid rates, such as Kerala and Maharashtra, could “skew the picture,” according to Vidyasagar. </p>.<p>A surge in Covid cases in Kerala, which is now leading the country in the number of daily infections and total cases, <a href="https://www.deccanherald.com/opinion/first-edit/kerala-s-covid-19-surge-a-concern-1014807.html" target="_blank">has already caused concern </a>with a central team visiting the state to assess the situation.</p>.<p>Its neighbouring state, Karnataka, has also been witnessing a <a href="https://www.deccanherald.com/state/covid-19-concern-as-karnataka-districts-along-kerala-border-inch-towards-5-tpr-1014794.html" target="_blank">surge in Covid-19 cases in districts along the Kerala border</a>. As per the state war room report, four districts along the Kerala border have a weekly TPR (average of seven days from July 23 to 29) inching towards 5 per cent: Dakshina Kannada (4.42%), Chikkamagaluru (3.67%), Kodagu (3.44%) and Udupi (3.39%). </p>.<p>On Sunday, for the first time, Dakshina Kannada <a href="https://www.deccanherald.com/state/top-karnataka-stories/dakshina-kannada-overtakes-bengaluru-in-daily-covid-cases-1015323.html" target="_blank">overtook Bengaluru Urban in the number of Covid cases </a>posted on a single day. It recorded 410 new cases, while Bengaluru Urban registered 409 fresh infections. This represents a 75.7 per cent increase in cases in Dakshina Kannada over the past week.</p>.<p>This forced the Karnataka government<a href="https://www.deccanherald.com/state/top-karnataka-stories/vaccinated-travellers-from-kerala-maharashtra-still-need-rt-pcr-test-report-to-enter-karnataka-1014890.html" target="_blank"> to tighten norms for travellers from Kerala and Maharashtra</a>. All those travelling to Karnataka from these two states will now have to produce a RT-PCR negative certificate that is not older than 72 hours, apart from showing a vaccination certificate stating that the person has taken both doses of vaccine.</p>.<p>Similarly, Tamil Nadu, which saw a marginal increase in Covid cases in the past few days, <a href="https://www.deccanherald.com/national/south/rt-pcr-test-mandatory-for-those-entering-tamil-nadu-from-kerala-1015246.html" target="_blank">has made it mandatory to carry RT-PCR test reports</a> from August 5 for those coming from Kerala. The state government has also empowered district collectors <a href="https://www.deccanherald.com/national/south/as-covid-19-cases-rise-marginally-tamil-nadu-goes-for-local-containment-1015278.html" target="_blank">to go in for local containment efforts</a>, including imposing additional restrictions in their area if the need arises.</p>.<p>Conjuring up fears of a third Covid-19 wave, a nationwide survey <a href="https://www.deccanherald.com/national/survey-indicates-travel-plans-by-28-amid-third-covid-wave-fears-1015350.html" target="_blank">has revealed that 28 per cent of the respondents have travel plans in August-September</a>. A substantial 54 per cent of these travellers indicated that they would visit their friends and family, while 26 per cent want to head to holiday destinations, the survey report said.</p>.<p>On the Covid-19 vaccine front, a recent ICMR study said that Bharat Biotech's <a href="https://www.deccanherald.com/national/covaxin-effective-against-delta-plus-variant-icmr-study-1015437.html" target="_blank">Covaxin is effective against the Delta Plus variant</a>.</p>.<p>In another major development, Mumbai-based Glenmark pharmaceuticals has signed a long term strategic partnership with Canadian biotech firm SaNOtize Research & Development Corp. to manufacture, market and distribute its breakthrough <a href="https://www.deccanherald.com/business/business-news/glenmark-pharma-signs-agreement-for-nasal-spray-used-for-covid-19-treatment-1015420.html" target="_blank">Nitric Oxide Nasal Spray (NONS) for Covid-19 treatment</a> in India and other Asian markets. </p>.<p>Meanhwile, the drug regulator said on Monday that Johnson & Johnson <a href="https://www.deccanherald.com/business/jj-withdraws-proposal-for-speedy-covid-19-vaccine-approval-in-india-1015449.html" target="_blank">withdrew its proposal </a>seeking accelerated approval of its Covid-19 vaccine in the country, without giving additional details. The US-based company had said in April it was seeking an approval to conduct a clinical study of its Janssen Covid-19 vaccine candidate in India. Trials in the United States at that time were paused on reports of rare blood clots.</p>